The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination
Journal of Neurochemistry · 2025
DOI: 10.1111/jnc.70260 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neurochemistry, 2025. Verfasst von V S Mattera. Beteiligte Einrichtung: Departamento de Química Biológica e Instituto de Química y Fisicoquímica Biológica (IQUIFIB), Facultad de Farmacia y Bioquímica, Universidad de Bueno…. Hauptthemen laut MEDLINE: Extracellular Vesicles, Transferrin, Remyelination. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Argentine Scientific and Technological Research Fund (Fondo para la Investigación Científica y Tecnológica, FONCyT).
Abstract (Originalsprache)
Oligodendrocytes (OLs), the myelinating glial cells of the central nervous system (CNS), are impaired in demyelinating diseases such as multiple sclerosis (MS). OL loss is characterized by inflammation, immune cell activity, and a failure of remyelination due to oligodendrocyte dysfunction and death, ultimately leading to demyelination and axonal damage. Given their central role in maintaining CNS integrity, therapeutic strategies aimed at protecting or restoring OL function are essential. Moreover, the limited permeability of the blood–brain barrier to many therapeutic compounds remains a major challenge, highlighting the need for innovative delivery approaches. Among these, the intranasal (IN) route has emerged as a promising noninvasive strategy for targeting the CNS. Within this therapeutic framework, Transferrin (Tf), a glycoprotein involved in iron homeostasis, has been shown to promote both developmental myelination and remyelination by redistributing and delivering iron, an essential cofactor for OL maturation and oxidative metabolism. In parallel, extracellular vesicles (EVs) have gained increasing attention as mediators of intercellular communication and potential drug delivery vehicles to the brain, offering advantages such as minimal immunogenicity, efficient cellular uptake, and cargo protection from degradation. In this review, the potential of EVs as biological carriers of molecules to promote remyelination is discussed, with a particular focus on Tf delivered via the intranasal route, as well as the cellular mechanisms underlying this internalization. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Química Biológica e Instituto de Química y Fisicoquímica Biológica (IQUIFIB), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires-CONICET, Buenos Aires, Argentina.
ORCID-Profile: V S Mattera
Förderung
- Argentine Scientific and Technological Research Fund (Fondo para la Investigación Científica y Tecnológica, FONCyT)
Zitieren
APA
Mattera, V. S. (2025). The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70260
Vancouver
Mattera VS. The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination. Journal of Neurochemistry. 2025. doi:10.1111/jnc.70260
BibTeX
@article{Mattera2025,
author = {Mattera, V S},
title = {The Intranasal Administration of Transferrin‐Loaded Extracellular Vesicles Enhances Remyelination},
journal = {Journal of Neurochemistry},
year = {2025},
doi = {10.1111/jnc.70260}
}
EUVIMED